The colorimetric lateral flow assay (CLFA, also known as test strip) is a widely used point-of-
care diagnostic technology. It has been a challenge to significantly improve the detection …

Lateral flow immunoassay (LFIA) with gold nanoparticles (AuNPs) as signal reporters is a
popular point-of-care diagnostic technique. However, given the weak absorbance of …

During the recent several decades, lateral flow immunoassay (LFIA) constructed with gold
nanoparticle (AuNP) has been widely utilized to conveniently detect target analyte …

The lateral flow immunoassay (LFIA) strip has been one of the classic but dominant tools in
the point of care (POC) detection with multiple advantages (eg, portability and simplicity). As …

Lateral flow immunoassays (LFIAs) have been developed rapidly in recent years and used
in a wide range of application at point-of-care-testing (POCT), where small biomolecules can …

Benefiting from many advantages including low cost, simple operation and low dependence
on analytical instruments, lateral flow immunoassay (LFIA) has been widely used in many …

As a representative technology for point‐of‐care testing (POCT), lateral flow immunoassay
(LFIA) has been broadly used to detect analytes in many fields. However, its clinical …

A gold nanoparticles (AuNPs) enhancement strategy for lateral flow immunoassays (LFIAs)
was previously reported to improve assay sensitivity. The multi-steps of detection resulted in …

The nanomaterials based lateral flow immunoassays (LFIAs) have been widely used for on-
site detection of small molecules contaminants. Nevertheless, their practical applications are …

Lateral flow assays (LFAs) have become the most common biosensing platforms for point-of-
care testing due to their compliance with the ASSURED (affordable, sensitive, specific, user …